Jun 25, 2004 by Roger NusbaumGetting Answers About Ask JeevesWhat does the future hold for this Internet search company?
Jun 24, 2004 by Roger NusbaumMine Safety in NumbersHere's how this little stock helps workers and shareholders.
Jun 23, 2004 by Roger NusbaumCould Taser Stun the Market?This Fool looks beyond the company's expensive ratios.
Jun 22, 2004 by Roger NusbaumThe House of Morgan StanleyDespite its warts, the brokerage firm should continue to thrive.
Jun 17, 2004 by Roger NusbaumIs Gemstar Really a Strong Buy?The TV Guide company has been dubbed that, but this writer disagrees.
Jun 15, 2004 by Roger NusbaumPraxair's Not Just Hot AirThe chemical company continues to provide impressive dividends.
Jun 9, 2004 by Roger NusbaumQuanex's Quiet GrowthWe take a look at a longtime steel company that grows stealthily.
Jun 9, 2004 by Roger NusbaumDon't Blame It on RIODespite a correction, this Brazilian company still looks like a winner.
Jun 8, 2004 by Roger NusbaumFederal Signal Is GridlockedHere's a small-cap stock that is unlikely to move.
Jun 7, 2004 by Roger NusbaumAIG's Obstacles to GrowthThere are several. One is that the company is already so big.
Jun 4, 2004 by Roger NusbaumIDEXX Labs a Boring Biotech?Sometimes, boring's not so bad. Take this company, for instance.
Jun 2, 2004 by Roger NusbaumPOZEN Is a PoserHere's a great example of the riskiest type of biotech stock.
Jun 2, 2004 by Roger NusbaumMahalo, Hawaiian ElectricShould this utility be part of your well-rounded investment portfolio?
May 25, 2004 by Roger NusbaumSigning Off on SinaDon't believe the hype. Know the risks before getting into Sina.
May 19, 2004 by Roger NusbaumGilead ShinesThis biotech company looks strong because investors can relate to its products.